VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 139 filers reported holding VIRIDIAN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,913,586 | -38.1% | 2,993,063 | -3.9% | 0.00% | -50.0% |
| Q2 2023 | $74,132,850 | +5.1% | 3,116,135 | +12.4% | 0.00% | 0.0% |
| Q1 2023 | $70,554,941 | -12.5% | 2,773,386 | +0.4% | 0.00% | -33.3% |
| Q4 2022 | $80,665,052 | +98.4% | 2,761,556 | +39.3% | 0.00% | +200.0% |
| Q3 2022 | $40,653,000 | +147.0% | 1,982,062 | +39.3% | 0.00% | 0.0% |
| Q2 2022 | $16,462,000 | +482.7% | 1,422,824 | +831.3% | 0.00% | – |
| Q1 2022 | $2,825,000 | -6.7% | 152,775 | -0.2% | 0.00% | – |
| Q4 2021 | $3,028,000 | +262.2% | 153,126 | +201.2% | 0.00% | – |
| Q3 2021 | $836,000 | -9.0% | 50,841 | +1.2% | 0.00% | – |
| Q2 2021 | $919,000 | +78.1% | 50,252 | +62.7% | 0.00% | – |
| Q1 2021 | $516,000 | – | 30,887 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $78,863,057 | 13.28% |
| COMMODORE CAPITAL LP | 2,020,166 | $59,009 | 8.89% |
| ACUTA CAPITAL PARTNERS, LLC | 396,500 | $11,581,765 | 7.13% |
| Fairmount Funds Management LLC | 1,369,623 | $40,006,688 | 6.35% |
| Paradigm Biocapital Advisors LP | 1,751,167 | $51,151,588 | 6.00% |
| Vivo Capital, LLC | 1,678,207 | $49,020 | 5.64% |
| TCG Crossover Management, LLC | 983,610 | $28,731,248 | 5.07% |
| Kynam Capital Management, LP | 1,034,697 | $30,223,499 | 4.64% |
| Octagon Capital Advisors LP | 824,200 | $24,074,882 | 3.75% |
| Logos Global Management LP | 1,000,000 | $29,210,000 | 3.42% |